Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Ipsen

Status: Withdrawn

Conditions: Acromegaly

Study type: Observational

Funder types: Industry

Identifiers

NCT05184231

CLIN-52030-454

Details and patient eligibility

About

The purpose of the protocol is to achieve an in-depth understanding of the current satisfaction status of somatostatin analogue (SSA) treatment for acromegaly through patient and physician surveys.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

For Patients:

• Age 18 years or older
• Diagnosed with acromegaly
• Receiving current SSA injections for acromegaly treatment for at least 3 months
• Signed electronic Informed Consent Form (eICF)

For Physicians:

• Licensed endocrinologists or neurosurgeons
• Having prescribed SSAs for at least five patients with acromegaly in the past 6 months
• Signed eICF

Exclusion criteria

• Patients will not be included in the survey if they meet any of the following criteria:
• Patients who are not able to successfully complete the questionnaire independently
• Pregnant patients

Trial design

0 participants in 2 patient groups

Patient cohort

Physician cohort